Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nalmefene Efficacy Study I: Randomised, Double-blind, Placebo-controlled, Parallel-group, Efficacy Study of 20 mg Nalmefene, As-needed Use, in Patients With Alcohol Dependence

Next Previous
Trial Profile

Nalmefene Efficacy Study I: Randomised, Double-blind, Placebo-controlled, Parallel-group, Efficacy Study of 20 mg Nalmefene, As-needed Use, in Patients With Alcohol Dependence

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 17 Sep 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nalmefene (Primary)
  • Indications Alcohol withdrawal
  • Focus Pharmacogenomic; Registrational; Therapeutic Use
  • Acronyms ESENSE1
  • Sponsors Lundbeck A/S

    • Most Recent Events

    • 09 Jun 2016 Results of a predictive microsimulation model assessing public health benefits of nalmefene and psychosocial support for the reduction of alcohol consumption from ESENSE1, ESENSE2 and SENSE trials published in the Applied Health Economics and Health Policy
    • 09 Oct 2013 Pooled results for treatment response and quality of life measures in patients with high drinking risk level presented at the 26th Annual Congress of the European College of Neuropsychopharmacology.
    • 09 Oct 2013 Pooled results for treatment adherence in patients with high drinking risk level presented at the 26th Annual Congress of the European College of Neuropsychopharmacology.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top